Compounds > indazoles
Page last updated: 2024-08-21

indazoles and Diabetic Retinopathy

indazoles has been researched along with Diabetic Retinopathy in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, W; Gao, X; Hao, X; Ke, X; Ma, N; Wang, W; Wu, J; Zhang, H; Zhang, Z; Zhao, M1
Kompella, UB; Rao, VR; Scheinman, RI; Thakur, A1
Eibl, K; Haritoglou, C; Kampik, A; Kernt, B; Kernt, M; Liegl, RG; Thiele, S; Ulbig, MW1
Benitez del Castillo, JM; Castillo, A; Diaz, D; Garcia-Sanchez, J; Jimenez-Alfaro, I; Ortega, P; Toledano, N1

Other Studies

4 other study(ies) available for indazoles and Diabetic Retinopathy

ArticleYear
Inhibition of Hypoxia-Induced Retinal Angiogenesis by Specnuezhenide, an Effective Constituent of Ligustrum lucidum Ait., through Suppression of the HIF-1α/VEGF Signaling Pathway.
    Molecules (Basel, Switzerland), 2016, Dec-21, Volume: 21, Issue:12

    Topics: Angiogenesis Inhibitors; Animals; Cell Hypoxia; Cell Line; Cobalt; Diabetic Retinopathy; Disease Models, Animal; Epithelial Cells; Gene Expression Regulation; Glucosides; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Indazoles; Ligustrum; Plant Extracts; Pyrans; Rats; Rats, Sprague-Dawley; Retinal Neovascularization; Retinal Pigment Epithelium; Signal Transduction; Vascular Endothelial Growth Factor A

2016
Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage.
    Microvascular research, 2011, Volume: 82, Issue:3

    Topics: Administration, Ophthalmic; Animals; Blood Glucose; Blood Proteins; Blood-Retinal Barrier; Body Weight; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Indazoles; Leukocytes; Leukostasis; Macular Edema; Male; Molecular Targeted Therapy; Ophthalmic Solutions; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Inbred BN; Sulfonamides; Time Factors; Vitreous Body

2011
Axitinib modulates hypoxia-induced blood-retina barrier permeability and expression of growth factors.
    Growth factors (Chur, Switzerland), 2012, Volume: 30, Issue:1

    Topics: Adult; Aged; Axitinib; Blood-Retinal Barrier; Cell Hypoxia; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Diabetic Retinopathy; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Indazoles; Intercellular Signaling Peptides and Proteins; Macular Edema; Middle Aged; Pigment Epithelium of Eye; Receptor, Platelet-Derived Growth Factor beta; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2012
Effect of bendazac lysine on lens and retina in diabetics.
    Documenta ophthalmologica. Advances in ophthalmology, 1994, Volume: 86, Issue:4

    Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Blood-Retinal Barrier; Capillary Permeability; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Female; Fluorophotometry; Humans; Indazoles; Lens, Crystalline; Male; Middle Aged; Retina

1994